Carlyle completed the €250m investment in Sanoptis.

Carlyle, an American multinational private equity, alternative asset management, and financial services corporation, completed the €250m investment in Sanoptis, an ophthalmology services provider. "We are very excited that Carlyle is joining us as a new partner alongside our lead investor GBL. This capital increase is, above all, excellent news for our network. It underscores our commitment to our mission of making high-quality ophthalmology accessible to everyone," Volker Wendel, Sanoptis CEO and Founder.